ASSESSMENT OF ORAL GLYCINE AND LYSINE THERAPY ON RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS AND TRANSFORMING GROWTH FACTOR BETA EXPRESSION IN THE KIDNEY OF STREPTOZOTOCIN-INDUCED DIABETIC RATS IN COMPARISON WITH NORMAL RATS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

HEIDARY SOMAYEH SADAT; BATHAIE SAYEDEH ZAHRA; BAHMANI FERESHTEH; MOSHTAGHI KASHANIAN GHOLAMREZA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Kerman University of Medical Sciences Year:2014 | Volume:21 | Issue:6 Page(s): 454-468

Download Full-Text

Persian Verion

View:

1,180

Download:

Cites:

Information Journal Paper

Title

ASSESSMENT OF ORAL GLYCINE AND LYSINE THERAPY ON RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS AND TRANSFORMING GROWTH FACTOR BETA EXPRESSION IN THE KIDNEY OF STREPTOZOTOCIN-INDUCED DIABETIC RATS IN COMPARISON WITH NORMAL RATS

Author(s)

HEIDARY SOMAYEH SADAT | BATHAIE SAYEDEH ZAHRA | BAHMANI FERESHTEH | MOSHTAGHI KASHANIAN GHOLAMREZA | Issue Writer Certificate

Keywords

RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE)Q2

ADVANCED GLYCATION END PRODUCTS (AGES)Q2

GLYCINEQ2

LYSINEQ2

CHEMICAL CHAPERONESQ2

Abstract

Background & Aims: Today, diabetic nephropathy is considered to be one of the most common causes of end stage renal disease. Uncontrolled hyperglycemia, and consequently, production of advanced glycation end products activate pathways which play key roles in diabetic nephropathy. Among these pathways, high expression of receptor for advanced glycation end products (RAGE) and transforming growth factor beta (TGFb) are notable. In this study, in order to find compounds which can prevent the incidence or progression of diabetic nephropathy, we examined the effects of GLYCINE and LYSINE amino acids on expression of RAGE and TGFb in kidney tissue of diabetic rats.Methods: After rendering rats with diabetes with streptozotocin (STZ), they were divided into different groups and were treated with oral 1% GLYCINE and 0.1% LYSINE in drinking water for 12 weeks. Blood glucose and serum AGEs were measured during this time. Changes in RAGE and TGFb expression were assessed by semi quantitative reverse transcription polymerase chain reaction (RT-PCR) method.Results: Results show that both GLYCINE and LYSINE administration for 12 weeks not only caused a significant reduction in blood glucose and AGEs in diabetic rats, but also led to a significant reduction in RAGE and TGFb expression in comparison to non-treated diabetic rats.Conclusion: These results show that oral GLYCINE and LYSINE, as CHEMICAL CHAPERONES, have the ability to prevent diabetic nephropathy by decreasing RAGE and TGFb expression. This may be due to the effect of these CHEMICAL CHAPERONES in the reduction of hyperglycemia and serum AGEs in diabetic rats. Since the positive effects of these amino acids in diabetic nephropathy have been observed in previous studies, the determination of their dose in future studies seems necessary.

Cites

No record.

References

No record.

Cite

APA: Copy

HEIDARY, SOMAYEH SADAT, BATHAIE, SAYEDEH ZAHRA, BAHMANI, FERESHTEH, & MOSHTAGHI KASHANIAN, GHOLAMREZA. (2014). ASSESSMENT OF ORAL GLYCINE AND LYSINE THERAPY ON RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS AND TRANSFORMING GROWTH FACTOR BETA EXPRESSION IN THE KIDNEY OF STREPTOZOTOCIN-INDUCED DIABETIC RATS IN COMPARISON WITH NORMAL RATS. JOURNAL OF KERMAN UNIVERSITY OF MEDICAL SCIENCES, 21(6), 454-468. SID. https://sid.ir/paper/356/en

Vancouver: Copy

HEIDARY SOMAYEH SADAT, BATHAIE SAYEDEH ZAHRA, BAHMANI FERESHTEH, MOSHTAGHI KASHANIAN GHOLAMREZA. ASSESSMENT OF ORAL GLYCINE AND LYSINE THERAPY ON RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS AND TRANSFORMING GROWTH FACTOR BETA EXPRESSION IN THE KIDNEY OF STREPTOZOTOCIN-INDUCED DIABETIC RATS IN COMPARISON WITH NORMAL RATS. JOURNAL OF KERMAN UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2014;21(6):454-468. Available from: https://sid.ir/paper/356/en

IEEE: Copy

SOMAYEH SADAT HEIDARY, SAYEDEH ZAHRA BATHAIE, FERESHTEH BAHMANI, and GHOLAMREZA MOSHTAGHI KASHANIAN, “ASSESSMENT OF ORAL GLYCINE AND LYSINE THERAPY ON RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS AND TRANSFORMING GROWTH FACTOR BETA EXPRESSION IN THE KIDNEY OF STREPTOZOTOCIN-INDUCED DIABETIC RATS IN COMPARISON WITH NORMAL RATS,” JOURNAL OF KERMAN UNIVERSITY OF MEDICAL SCIENCES, vol. 21, no. 6, pp. 454–468, 2014, [Online]. Available: https://sid.ir/paper/356/en

Related Journal Papers